Skip to content

New Method for the Collection of the Output From the Ileostoma Using a Intestinal Tampon

First Study: InterPoc's Safety and Tolerability in Adults With Second Study: Safety and Functionality of InterPoc

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05891041
Enrollment
24
Registered
2023-06-06
Start date
2023-04-26
Completion date
2023-10-01
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma

Brief summary

1 study: A pilot study of 8 adults with ileostomy was included in this trial of first in human with InterPoc™, an absorbent intestinal tampon safety and feasibility in humans with ileostomies. Study 2: A study in total with 24 participants, evaluating both the safety but also the functionality of InterPoc in humans with ileostomies.

Detailed description

Approximately 1 million individuals with ileostomies face limitations in design and complications with traditional stoma bags dating back to the 1950s. Colostomy care alternatives are unavailable for ileostomy patients, prompting the development of InterPoc™, an absorbent intestinal tampon. The first study aims to assess its safety and feasibility in humans, while the second study focuses of the overall safety and functionality of the tampon in all 24 participants.

Interventions

None listed

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age of at least 18 Ileostoma at least created 6 months prior Ileostoma opening of at least 15 mm

Exclusion criteria

Inflamatory condition in the stoma or other intestine diagnosed within 2 months of the study Parastomal hernia daily output above 2 litters

Design outcomes

Primary

MeasureTime frameDescription
Number of patients requiring pharmacological or surgical intervention due to the use of InterPOC for 6 hours6 hoursSafety of Interpoc during use

Secondary

MeasureTime frameDescription
Early warning score during interpoc use (vital signs Pulse, blood pressure, oxygen saturation, respiratory rate, temperature),6 hoursA low score is better than a high score
Scale (0-10) score of Discomfort, acid reflux, nausea6 hoursA low score is better than a high score
InterPoc™ weight before and after insertion6 hoursFor comparable
Leakage around the stoma pouch6 hoursScale: 1-3)
Pain during interpoc use6 hoursUsing the NRS from 0-10
InterPoc™ Skin Irritation6 hour(Scale: 1-3)
Insertion and removal resistance6 hourscale 1-3)
Food consumption6 hourdescriptive
Fecal output in stoma bag (ml) before and after the trail6 hoursscale 1-3

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026